Hairmax adds 5% minoxidil to hair restoration lineup

Hairmax launched Men's 5% Minoxidil Topical Solution on June 17, 2026, expanding its hair restoration portfolio beyond FDA-cleared laser devices and scalp treatments. The move gives consumers another clinically proven option for hereditary hair loss and sets up a future women’s product rollout.

Why it matters: - Hairmax is widening its hair restoration stack beyond laser devices to include a drugstore-style topical treatment for hereditary hair loss. - The new product gives men another clinically proven option that can be used alone or alongside other Hairmax treatments. - The expansion matters because Hairmax is positioning a more complete routine for people trying to improve hair density and overall hair growth.

What happened: - Hairmax announced the launch of Hairmax Men's 5% Minoxidil Topical Solution on June 17, 2026. - The product joins Hairmax’s portfolio of FDA-cleared laser hair growth devices, hair care products and scalp treatments. - The topical solution uses 5% minoxidil, the FDA-approved active ingredient for hair regrowth. - Hairmax says the product is intended for men experiencing hereditary hair loss.

The details: - The topical treatment is designed as both a standalone treatment and part of a broader Hairmax hair restoration routine. - Hairmax says its combined lineup allows consumers to build a personalized hair growth regimen tailored to individual needs and goals. - The company says it has more FDA clearances and clinical studies than any other laser hair growth brand. - Hairmax says it has pioneered laser hair growth technology since 2000. - Hairmax says it has eight FDA clearances and is backed by seven clinical studies. - Hairmax says its laser devices are manufactured with ISO certification, GMP compliance and medical device licenses worldwide.

Between the lines: - The launch broadens Hairmax from a laser-first brand into a more rounded hair-loss platform. - The company is also leaning into combination therapy, a setup many physicians view as useful because minoxidil and low-level laser therapy work through different biological pathways. - Hairmax President Mike Nassar said the added minoxidil product expands the range of clinically proven solutions for customers seeking either a single treatment or a more comprehensive approach. - Hairmax’s clinical director, Dr. Taylor Bullock, said minoxidil and low-level laser therapy are complementary options for many people seeking to improve hair density and overall growth.

What's next: - Hairmax plans to add Hairmax Women's 2% Minoxidil in a future launch. - The company says the next topical product would further expand its personalized hair growth offerings for men and women.

The bottom line: - Hairmax is betting that a broader, multi-step hair restoration system will strengthen its position in a crowded hair-loss market.